Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,881 to 1,900 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreatic Cancer and Immunotherapy: A Clinical Overview. | Cancers (Basel) | 2021 | 34439292 | PubTator, text mining | PubMed |
| Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | 34434928 | PubTator, text mining | PubMed |
| Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study. | NPJ Breast Cancer | 2021 | 34433812 | PubTator, text mining | PubMed |
| Profound Treg perturbations correlate with COVID-19 severity. | Proc Natl Acad Sci U S A | 2021 | 34433692 | PubTator, text mining | PubMed |
| Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. | Patterns (N Y) | 2021 | 34430923 | PubTator, text mining | PubMed |
| Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. | J Immunol Res | 2021 | 34426790 | PubTator, text mining | PubMed |
| The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer. | Front Cell Dev Biol | 2021 | 34422829 | PubTator, text mining | PubMed |
| Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis. | Front Oncol | 2021 | 34422633 | PubTator, text mining | PubMed |
| Optimizing T Cell-Based Therapy for Glioblastoma. | Front Immunol | 2021 | 34421912 | PubTator, text mining | PubMed |
| Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex. | J Biol Chem | 2021 | 34419446 | Swiss-Prot, curated | PubMed |
| Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients. | Front Cell Dev Biol | 2021 | 34414187 | PubTator, text mining | PubMed |
| Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. | Stem Cell Res Ther | 2021 | 34412685 | PubTator, text mining | PubMed |
| Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. | Brain Commun | 2021 | 34409288 | PubTator, text mining | PubMed |
| Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. | Front Cell Dev Biol | 2021 | 34409029 | PubTator, text mining | PubMed |
| Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus. | Front Immunol | 2021 | 34408748 | PubTator, text mining | PubMed |
| An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. | Clin Transl Sci | 2021 | 34405542 | PubTator, text mining | PubMed |
| Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype. | Int J Med Sci | 2021 | 34400883 | PubTator, text mining | PubMed |
| Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer. | Front Immunol | 2021 | 34394098 | PubTator, text mining | PubMed |
| Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities. | Front Immunol | 2021 | 34386017 | PubTator, text mining | PubMed |
| The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers. | BMC Immunol | 2021 | 34384367 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=95